A Phase 1a/b Study of IK-175 as a Single Agent and in Combination With Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumors and Urothelial Carcinoma

Clinical trial NCT04200963 · COMPLETED

Trial details

NCT number: NCT04200963
Sponsor: Ikena Oncology
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Urothelial Carcinoma Urothelial Carcinoma Bladder Bladder Cancer Bladder Disease Solid Tumor Solid Carcinoma Solid Tumor, Adult Metastatic Cancer Advanced Solid Tumor Advanced Cancer Metastatic Bladder Cancer Metastatic Urothelial Carcinoma

Start date: 2019-12-18
Primary completion: 2023-07-18
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.